Nasus Pharma NSRX
NYSE NSRX
$3.77 +0.20 (+5.60%)
As of: Sep 30, 2026 · 10:19 AM EDT

Nasus Pharma (NSRX) Debt Ratio (2024 - 2025)

Updated

Nasus Pharma's (NSRX) Debt Ratio came in at 4.01 for Q2 2025.

Analysis

Nasus Pharma (NSRX) Debt Ratio (2024 - 2025) Analysis & Trends

For FY2024, Nasus Pharma's Debt Ratio stood at 2.51.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Nasus Pharma 32.00 Mn 32.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.01
Dec 31, 2024 2.51
API Access

Nasus Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NSRX&period=max&api_key=YOUR_API_KEY